We help companies optimize their vaccines’ antigenicity and immunogenicity by analyzing millions of genomes of viruses and immunological and epidemiological data. Our mission is to accelerate vaccine discovery with AI. We provide the technology and Machine Learning models that accelerate the drug development process and increase vaccine efficacy against current and future variants of the viruses. We want to fully unlock the potential of mRNA by optimizing the drug development pipeline and automating the process of finding vaccine candidates. We started Deepflare with the goal of analyzing genomes of SARS-CoV-2 and helping to develop. To achieve that, we developed an AI platform that analyses millions of viruses, predicts future variants, and quickly finds sequences to contain in a drug and vaccine. Deepflare can be used to understand the behavior of the virus. Get insights into the evolution of the epidemic. Also, predict future virus mutations and work with pharmaceutical companies and laboratories to help fight the outbreaks and save lives. In Deepflare, we are developing tools never to be scared about viruses and diseases. We were established in 2020 with the simple goal of using AI to combat the problem of virus mutation. We build systems to help pharmaceutical companies develop better, more effective vaccines and PCR tests. We believe in the future where nobody will fear virus mutation. Using cutting-edge AI techniques, the effectiveness of vaccines can be immensely improved.